Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
58.61
-1.00 (-1.68%)
At close: Nov 13, 2024, 4:00 PM
59.26
+0.65 (1.11%)
After-hours: Nov 13, 2024, 5:52 PM EST
Halozyme Therapeutics Revenue by Segment
History
| Date | Royalties | Product Sales | s Under Collaborative Agreements Revenue |
|---|---|---|---|
| Sep 30, 2024 | 522.62M | 303.73M | 121.00M |
| Jun 30, 2024 | 482.00M | 303.64M | 87.67M |
| Mar 31, 2024 | 468.82M | 298.64M | 95.53M |
| Dec 31, 2023 | 447.87M | 300.85M | 80.53M |
| Sep 30, 2023 | 431.79M | 282.42M | 66.50M |
| Jun 30, 2023 | 416.91M | 257.27M | 99.47M |
| Mar 31, 2023 | 390.51M | 229.68M | 84.79M |
| Dec 31, 2022 | 360.48M | 191.03M | 108.61M |
| Sep 30, 2022 | 317.13M | 156.92M | 106.57M |
| Jun 30, 2022 | 276.14M | 120.54M | 90.80M |
| Mar 31, 2022 | 236.58M | 104.60M | 130.39M |
| Dec 31, 2021 | 203.90M | 104.22M | 135.19M |
| Sep 30, 2021 | 173.26M | 109.63M | 180.12M |
| Jun 30, 2021 | 138.63M | 93.63M | 180.24M |
| Mar 31, 2021 | 108.70M | 69.61M | 152.96M |
| Dec 31, 2020 | 88.60M | 55.99M | 123.01M |
| Sep 30, 2020 | 73.83M | 46.23M | 79.50M |
| Jun 30, 2020 | 66.51M | 66.38M | 47.58M |
| Mar 31, 2020 | 68.77M | 65.81M | 29.82M |
| Dec 31, 2019 | 69.90M | 66.05M | 60.05M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.